Skip to main content
Log in

Seroquel: electrophysiological profile of a potential atypical antipsychotic

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Extracellular single unit recording techniques were employed to compare the effects of seroquel with the reference antipsychotic (AP) agents clozapine and haloperidol in electrophysiological tests that may predict AP activity. Seroquel and clozapine were differentially more active in reversing the inhibitory actions ofd-amphetamine on mesolimbic (A10) than nigrostriatal (A9) dopamine (DA)-containing neurons, whereas haloperidol exhibited the opposite selectivity. In cell population studies, acute treatment with seroquel and clozapine selectively increased the number of spontaneously active A10 DA cells, which was found to correlate with the ability of both these drugs to cause depolarization inactivation (DI) of A10 DA cells following repeated (28 day) administration. This profile of activity was unlike that of haloperidol, which acutely caused a nonselective increase in the number of active A9 and A10 DA cells, associated with the ability of this agent to cause DI of both A9 and A10 DA cells after repeated treatment. Since DI of A10 DA cells may be correlated with AP efficacy whereas DI of A9 DA cells may predict the ability of an AP to cause extrapyramidal side effects (EPS) and tardive dyskinesia (TD), seroquel, like clozapine, may be an atypical AP with a reduced likelihood for producing EPS/TD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain. Brain Res Bull 16:517–525

    Google Scholar 

  • Bunney BS, Aghajanian GK (1976) The effects of antipsychotic drugs on the firing of dopaminergic neurons: a reappraisal. In: Sedvall G, Uvnos B, Zotteman V (eds) Antipsychotic drugs, pharmacodynamics and pharmacokinetics. Wenner-Gren Center International Symposium Series, Pergamon, New York, pp 305–318

    Google Scholar 

  • Bunney BS, Grace AA (1978) Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic activity. Life Sci 23:1715–1728

    Google Scholar 

  • Bunney BS, Walters JR, Roth RH, Aghajanian GK (1973) Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther 185:560–571

    Google Scholar 

  • Bunney BS, Roth RH, Aghajanian GK (1975) Effects of molindone on central dopaminergic neuronal activity and metabolism: similarity to other neuroleptics. Psychopharmacol Commun 1:349–358

    Google Scholar 

  • Carter CJ, Pycock CJ (1977) Possible importance of 5-hydroxytryptamine in neuroleptic-induced catalepsy in rats. Br J Pharmacol 60:267–268

    Google Scholar 

  • Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3:1607–1619

    Google Scholar 

  • Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two sub-populations of midbrain dopamine neurons. J Neurosci 5:2539–2544

    Google Scholar 

  • Costall B, Fortune DH, Naylor RJ, Marsden CD, Pycock C (1975) Serotonergic involvement with neuroleptic catalepsy. Neuropharmacology 14:859–868

    Google Scholar 

  • Goldstein JM, Litwin LC, Sutton EB, Malick JB (1986) The role of 5-HT2 receptor blockade on amphetamine (AMP) inhibition of dopamine (DA) cell firing. Fed Proc 45:436

    Google Scholar 

  • Goldstein JM, Litwin LC, Malick JB (1987) Ritanserin increases spontaneous activity of A9 and A10 dopamine neurons. Fed Proc 46:966

    Google Scholar 

  • Goldstein JM, Litwin LC (1988) Antipsychotic-like activity of ritanserin following chronic treatment in rats. FASEB J 2:A1404

    Google Scholar 

  • Goldstein JM, Litwin LC, Sutton EB, Malick JB (1989) Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity. J Pharmacol Exp Ther 249:673–680

    Google Scholar 

  • Grace AA, Bunney BS (1983) Intracellular and extracellular electrophysiology of nigral dopamine neurons. 1. Identification and characterization. Neuroscience 10:301–315

    Google Scholar 

  • Grace AA, Bunney BS (1986) Induction of depolarization block in midbrain neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J Pharmacol Exp Ther 238:1092–1100

    Google Scholar 

  • Hyttel J, Larsen JJ, Christensen AV, Arnt J (1985) Receptor-binding profiles of neuroleptics. In: Casey DE, Chase TN, Christensen AV, Gerlach J, (eds) Dyskinesia: research and treatment. Springer, Berlin Heidelberg New York, pp 9–18

    Google Scholar 

  • Litwin LC, Goldstein JM, Sutton EB, Malick JB (1986) Effects of altanserin, a selective 5-HT2 antagonist, on amphetamine-induced suppression of dopamine (DA) cell firing. Pharmacologist 28:109

    Google Scholar 

  • Migler BM, Malick JB, Warawa E (1993) Seroquel: behavioral effects in conventional and novel tests for atypical antipsychotic drugs. Psychopharmacology (this issue)

  • Miller JJ, Richardson TL, Fibiger HC, McLennan H (1975) Anatonical and electrophysiological identification of a projection from the mesencephalic raphe to the caudate putamen in the rat. Brain Res 97:133–138

    Google Scholar 

  • Olpe HR, Koella WP (1977) The response of striatal cells upon stimulation of the dorsal and median raphe nuclei. Brain Res 122:357–360

    Google Scholar 

  • Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, Academic Press, New York

    Google Scholar 

  • Saller CF, Salama AI (1993) Seroquel: Biochemical profile of a potential atypical antipsychotic. Psychopharmacology (this issue)

  • Shimomura K, Satoh H, Hirai O, Mori J, Tomoi M, Terai T, Katsuki S, Moyoyama Y, Ono T (1982) The central antiserotonin activity of zotepine, a new neuroleptic, in rats. Jpn J Pharmacol 32:405–412

    Google Scholar 

  • Sulpizio A, Fowler PJ, Macko E (1978) Antagonism of fenfluramine-induced hyperthermia: a measure of central serotonin inhibition. Life Sci 22:1439–1446

    Google Scholar 

  • Svendsen O, Arnt J, Boeck V, Bogeso KP, Christensen AV, Hyttel J, Larsen JJ (1986) The neuropharmacological profile of tefludazine, a potential antipsychotic drug with dopamine and serotonin receptor antagonistic effects. Drug Dev Res 7:35–47

    Google Scholar 

  • Tamminga CA, Gerlach J (1987) New neuroleptics and experimental antipsychotics in schizophrenia, In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1129–1140

    Google Scholar 

  • White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1057

    Google Scholar 

  • White FJ, Wang RY (1986) Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat. Neuropharmacology 25:995–1001

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldstein, J.M., Litwin, L.C., Sutton, E.B. et al. Seroquel: electrophysiological profile of a potential atypical antipsychotic. Psychopharmacology 112, 293–298 (1993). https://doi.org/10.1007/BF02244924

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02244924

Key words

Navigation